Related Experiment Videos
Hyponatremia in small cell lung cancer. Mechanisms not involving inappropriate ADH secretion
Abstract:
A 62-year-old man with small cell carcinoma (oat cell type) of the lung who had hyponatremia and renal sodium loss with inappropriate antidiuresis is reported. Plasma levels of arginine vasopressin (AVP) were not elevated inappropriately. Plasma levels of atrial natriuretic peptide (ANP), however, were high, and increased after water loading and hypertonic saline infusion. The renin-aldosterone axis was normal, as were adrenal, thyroid, and renal functions. Water restriction to 500 to 700 ml/d resulted in a rise in serum sodium. Analysis of the tumor tissue failed to demonstrate the presence of AVP or ANP. The findings (1) suggest that hyponatremia and renal sodium loss with inappropriate antidiuresis observed in the patient is due to an antidiuretic substance distinct from AVP, and (2) point to the possibility that hypersecretion of ANP may play a role in the pathophysiology.
Insights
This study reports a lung cancer patient with hyponatremia and sodium loss. A novel antidiuretic substance, not arginine vasopressin, may cause these symptoms, with atrial natriuretic peptide potentially involved.
Area of Science:
- Nephrology
- Endocrinology
- Oncology
Background:
- Small cell lung carcinoma (SCLC) can present with paraneoplastic syndromes.
- Hyponatremia with inappropriate antidiuresis is a recognized complication, often linked to arginine vasopressin (AVP).
Observation:
- A 62-year-old male SCLC patient exhibited hyponatremia and renal sodium loss with persistent antidiuresis.
- Plasma AVP levels were not elevated; however, atrial natriuretic peptide (ANP) levels were high and increased with fluid/saline challenges.
- Renal, adrenal, and thyroid functions were normal, and tumor tissue lacked AVP or ANP.
Findings:
- The patient's condition suggests an unidentified antidiuretic substance, distinct from AVP, is responsible for the observed hyponatremia and sodium wasting.
- Elevated and responsive ANP levels indicate a potential role in the pathophysiology of this patient's electrolyte imbalance.
Implications:
- This case highlights a potential novel mechanism for SCLC-associated hyponatremia beyond typical AVP secretion.
- Further research into non-AVP antidiuretic substances and the role of ANP in paraneoplastic syndromes is warranted.
- Understanding these mechanisms could lead to targeted therapies for electrolyte disturbances in cancer patients.